ALAS1 and porphyria: Most first-line anti-tuberculous drugs are associated with acute attacks of porphyria, its mechanism of action includes: (1) activation of ALAS1 transcription and translation by inducing CYP expression; (2) irreversible inhibition of CYP and compensative activation of heme synthesis; (3) ALAS1 expression induction.